Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00320047 · ClinicalTrials.gov registry record · NA
Effectiveness of Baclofen in the Treatment of People With Bulimia Nervosa or Binge Eating Disorder
A NA study of Eating Disorders and Bulimia Nervosa, sponsored by New York State Psychiatric Institute.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT00320047: Completed NA study of Eating Disorders and Bulimia Nervosa, sponsored by New York State Psychiatric Institute.
NCT00320047 is a NA study of Eating Disorders and Bulimia Nervosa that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 10 participants, below the 322-participant average among 37 other Eating Disorders trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00320047, a NA study of Eating Disorders and Bulimia Nervosa, has completed, sponsored by New York State Psychiatric Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will evaluate the effectiveness of the drug baclofen in reducing binge eating and associated food cravings in people with bulimia nervosa or binge eating disorder.
Conditions Studied
Interventions
- DRUG Baclofen
Study Locations (1)
New York
- Eating Disorders Clinic, New York State Psychiatric Institute - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2005-04 |
| Est. Completion | 2007-06 |
| Phase | NA |
What the finished NCT00320047 record still lists
NCT00320047 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 322-participant average among 37 other Eating Disorders trials with a reported enrollment target (97% lower).
The record links to 2 conditions, with Eating Disorders appearing as the primary indexed condition, and to 1 intervention - of which Baclofen is the first listed.
NCT00320047 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT00320047 about?
NCT00320047 is a clinical study titled "Effectiveness of Baclofen in the Treatment of People With Bulimia Nervosa or Binge Eating Disorder". This study will evaluate the effectiveness of the drug baclofen in reducing binge eating and associated food cravings in people with bulimia nervosa or binge eating disorder.
What is the current status of trial NCT00320047?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2005-04. Estimated completion is 2007-06.
What conditions does trial NCT00320047 study?
This clinical trial studies the following conditions: Eating Disorders, Bulimia Nervosa.
What interventions are being tested in trial NCT00320047?
The interventions under investigation include: Baclofen (DRUG).
Who is sponsoring clinical trial NCT00320047?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00320047 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Eating Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00320047's enrollment target sits among peer trials
10 38th of 37 the lowest of 37 other Eating Disorders trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Eating Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Facing Eating Disorder Fears for Anorexia Nervosa
RECRUITING · NA
-
Targeting Transdiagnostic Self-regulatory Factors and Eating Disorder Pathology Among Adults With BInge-spectrum Eating disOrders: A mHEALTH Interoceptive Exposure Intervention (the Bio-HEALTH Study)
RECRUITING · NA
-
Targeting Social Function in Anxiety and Eating Disorders
RECRUITING · NA
-
Diabetes Body Project 2
RECRUITING · NA
-
Acceptability and Feasibility of a Single-Session Online Parent-Focused Intervention Targeting Child Body Image Development
RECRUITING · NA
-
Developing an Artificial Intelligence (AI) Chatbot for Adolescents and Young Adults With Eating Disorders
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia